See more



i-Seed > Pharmaceutical


Pharmaceutical companies seek to rapidly detect and respond to adverse events, expedite the submission of New Drug Applications (NDA) and Abbreviated NDAs, and significantly cut the costs involved in developing new drugs. Organizations researching and developing new medicines and treatments face significant data challenges.
Insufficient visualization frameworks reduce creativity and limit researchers’ corrective analyses. Non-existent or overly obtrusive security models prevent collaboration. Without an enterprise-wide notification system, scientists miss alerts and warning signals. ISeed addresses these challenges so pharmaceutical companies can achieve their desired outcomes and people can benefit from new treatments.